Similarly to PDACs, neuroendocrine neoplasms are characterized by increased expression of multiple markers (Figure 1), including CA 19-9, CEA, CA 125, and α-fetoprotein (AFP). This evidence concerns the gene CEACAM5 and neuroendocrine neoplasm.